Pfizer’s stock has outperformed the broader markets as well as some of its peers over the last few weeks. While Pfizer stock grew 32.5% since the recent lows of March 23, the S&P 500 gained 28.0%. Looking at other pharmaceutical giants, Roche gained 29.3%, Novartis is up 18.8%, and Merck 20.2%...
